$6.83
-0.16-2.29%
Last update: Nov 6, 7:13 AM
Instil Bio Inc (TIL) Stock Price, Quote, News & History
TILNASDAQ
Instil Bio stock falls after the company ends development of its lead cancer drug and exits a licensing deal, raising new questions about its pipeline and next...
You can purchase shares of Instil Bio (NASDAQ:TIL) through any online brokerage.
Other companies in Instil Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Instil Bio has a consensus price target of $119.00.
The stock price for Instil Bio (NASDAQ: TIL) is $6.95 last updated November 6, 2026 at 7:13 AM EST.
There are no upcoming dividends for Instil Bio.
Instil Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Instil Bio.
Instil Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a...
